Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Share News (SPH)

  • There is currently no data for SPH

TechMARK movers: Restructuring costs hit Sinclair figures

Thu, 25th Feb 2010 14:36
Sinclair Pharma shares fell after it reported a slump into loss in 2009 but much of that was due to restructuring costs. However, another large loss is expected this year. New chief executive Chris Spooner has wasted little time in restructuring the business and boosting the sales expertise in the group. He ended Sinclair's distribution agreement with Orapharma Inc for Decapinol mouth rinse and plans to find another partner covering more of the market.Sinclair has negotiated new debt facilities of £9m and raised £18.2m from a share placing. The cash was used to finance the acquisition of Flammazine and Flammacerium (used for topical treatment of burns) from Solvay Pharmaceuticals for £16.8m. Sinclair had net debt of £12.3m at the end of 2009.Revenues were one-third lower than last year at £11m. Stripping out one-off payments, underlying revenues were 1% lower. Sinclair made a profit of £3.17m in 2008 but that was down to foreign exchange gains. The 2009 loss was £14.5m and around two-thirds of this was due to impairment charges and restructuring costs. Broker Singer has increased its forecast loss for 2010 from £6.1m to £15m. Stripping out exceptional charges the forecast loss rises from £1.7m to £2m. Singer has a 41p a share price target and says it believes that "the company is now better placed to deliver long term financial growth". Shares in IT services provider Logica are recovering following yesterday's fall on the announcement of figures for 2009. Revenues are expected to fall in the first half of 2010 and be flat for the year as a whole. FTSE TechMARK - RisersVisonic (VSC) 82.00p +2.50%Psion (PON) 92.00p +2.22%Ark Therapeutics (AKT) 14.50p +1.75%NXT (NTX) 14.75p +1.72%BT Group (BT.A) 117.60p +1.29%Intec Telecom Systems (ITL) 98.00p +1.29%COLT Telecom Group S.A. (COLT) 136.50p +1.11%Logica (LOG) 118.20p +1.11%Vodafone Group (VOD) 142.20p +0.85%Anite Group (AIE) 32.50p +0.78%FTSE TechMARK - FallersRenovo Group (RNVO) 27.25p -6.03%Sinclair Pharma (SPH) 29.50p -4.84%Oxford Instruments (OXIG) 232.00p -4.13%Gresham Computing (GHT) 19.00p -3.80%Vernalis (VER) 73.50p -3.61%Morse (MOR) 40.00p -2.44%Phoenix IT Group (PNX) 275.00p -2.22%Innovation Group (TIG) 12.50p -1.96%XP Power (XPP) 425.00p -1.96%Consort Medical (CSRT) 356.00p -1.79%

Related News

GLG Partners Doubles Sinclair Pharma Stake To 10.8% From 5.1% (ALLISS)
23 Oct 2018

GLG Partners Doubles Sinclair Pharma Stake To 10.8% From 5.1% (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Tuesday that GLG Partners LP doubled its stake in the company to 10.81%.GLG's previous holding in th...

Toscafund Asset Management Divests Entire Sinclair Pharma Holding (ALLISS)
19 Oct 2018

Toscafund Asset Management Divests Entire Sinclair Pharma Holding (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Friday that Toscafund Asset Management LLP divested its entire stake in the company.Prior to selling...

Sinclair Pharma News

Sinclair IS Pharma takes a hit but stays confident for full year
16 Jan 2014

Sinclair IS Pharma takes a hit but stays confident for full year

Shares in AIM 100 group Sinclair IS Pharma took a hit as the company reported a mixed trading update for the first half of its financial year, however...

UPDATE: Sinclair IS Pharma Like-For-Like Revenues Down, Confident For Full Year
16 Jan 2014

UPDATE: Sinclair IS Pharma Like-For-Like Revenues Down, Confident For Full Year

LONDON (Alliance News) - Sinclair IS Pharma PLC said Thursday that its like-for-like revenues declined 7% during the half year ended December 31, 2013...

Thursday broker round-up UPDATE
16 Jan 2014

Thursday broker round-up UPDATE

Aberdeen Asset Management: Canaccord Genuity cuts target price from 586p to 540p, while its buy recommendation remains unchanged. Anglo American: UBS...

Sinclair IS Pharma Sees Lower H1 LFL Sales; FY Results To Be In Line With View
16 Jan 2014

Sinclair IS Pharma Sees Lower H1 LFL Sales; FY Results To Be In Line With View

LONDON (Alliance News) - Sinclair IS Pharma PLC reported Thursday that its first-half revenues are projected to increase from last year, while like-fo...

UK MORNING BRIEFING: Shares Down; Sports Direct Ups Interest In Debenhams
16 Jan 2014

UK MORNING BRIEFING: Shares Down; Sports Direct Ups Interest In Debenhams

LONDON (Alliance News) - UK shares have opened mostly lower Thursday despite a strong lead from the US, as investors digest a rush of UK company annou...

UPDATE 1-Sinclair IS Pharma buys global rights to dermal gel Perfectha
7 Jan 2014

UPDATE 1-Sinclair IS Pharma buys global rights to dermal gel Perfectha

* Says deal to significantly add to earnings * Shares rise as much as 9 pct (Adds share movement; analyst quote) Jan 7 (Reuters) - Sinclair IS Pharm...